Receptores tipo Toll: entre el reconocimiento de lo

RECEPTORES TIPO TOLL: ENTRE EL RECONOCIMIENTO DE LO NO PROPIO INFECCIOSO Y LAS SEÑALES ENDÓGENAS DE PELIGRO VOL. 25 NUM. 2/ 2006
instruct dendritic cells to induce distinct Th responses via differential
modulation of extracellular signal-regulated kinase-mitogen-activated
protein kinase and c-Fos. J Immunol 2003; 171: 4984-4989.
23. Barton GM, Medzhitov R. Control of adaptive immune responses
by Toll-like receptors. Curr Opin Immunol 2002; 14: 380-383.
24. Pasare C, Medzhitov R. Toll-like receptors: balancing host resistance
with immune tolerance. Curr Opin Immunol 2003; 15: 677-682.
25. Lotz S, Aga E, Wilde I, van Zandbergen G, Hartung T, Solbachet
W, Laskay T. Highly purified lipoteichoic acid activates neutrophil
granulocytes and delays their spontaneous apoptosis via CD14
and TLR2. J Leukoc Biol 2004; 75: 467-477.
26. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate
human neutrophil function. Blood 2003; 102: 2660-2669.
27. Blander JM, Medzhitov R. Regulation of phagosome maturation
by signals from toll-like receptors. Science 2004; 304: 1014-1018.
28. Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania
A, et al. Synergistic up-regulation of vascular endothelial growth
factor expression in murine macrophages by adenosine A(2A)
receptor agonists and endotoxin. Am J Pathol 2002; 160: 2231-2244.
29. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman
Al, Boons GJ, et al. An angiogenic switch in macrophages involving
synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine
A(2A) receptors. Am J Pathol 2003; 163: 711-721.
30. Olah ME, Caldwell CC. Adenosine receptors and mammalian tolllike
receptors: synergism in macrophages. Mol Interv 2003; 3: 370-
374.
31. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, Karsan
A. Bacterial lipopolysaccharide directly induces angiogenesis
through TRAF6-mediated activation of NF-kappaB and c-Jun
N-terminal kinase. Blood 2003; 102: 1740-1742.
32. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge:
distinct Toll-like receptor 2 activators selectively induce different
classes of mediator production from human mast cells. J Immunol
2003; 170: 1625-1629.
33. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau
JM, Dy M, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially
activate human mast cells. Eur J Immunol 2003; 33: 899-906.
34. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of
mast cells by double-stranded RNA: evidence for activation through
Toll-like receptor 3. J Allergy Clin Immunol 2004; 114: 174-182.
35. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas
TA, et al. APC-independent activation of NK cells by the Toll-like
receptor 3 agonist double-stranded RNA. J Immunol 2004; 172:
138-143.
36. Sivori S, Falco M, Della CM, Carlomagno S, Vitale M, Moretta L,
et al. CpG and double-stranded RNA trigger human NK cells
by Toll-like receptors: induction of cytokine release and cytotoxicity
against tumors and dendritic cells. Proc Natl Acad Sci USA 2004;
101: 10116-10121.
128
37. Becker I, Salaiza N, Aguirre M, Delgado J, Carrillo-Carrasco N, Kobeh
LG, et al. Leishmania lipophosphoglycan (LPG) activates NK cells
through toll-like receptor-2. Mol Biochem Parasitol 2003; 130: 65-74.
38. Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M,
N´Guyen T, et al. Direct bacterial protein PAMP recognition by
human NK cells involves TLRs and triggers alpha-defensin
production. Blood 2004; 104: 1778-1783.
39. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M,
Demengeot J. Regulatory T cells selectively express toll-like receptors
and are activated by lipopolysaccharide. J Exp Med 2003; 197: 403-411.
40. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like
receptors in acquired immunity: up-regulation of TLR9 by BCR
triggering in naive B cells and constitutive expression in memory
B cells. Blood 2003; 101: 4500-4504.
41. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle
B, et al. IL-12p70-dependent Th1 induction by human B cells
requires combined activation with CD40 ligand and CpG DNA.
J Immunol 2004; 172: 954-963.
42. Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts
in innate immune responses of the intestine. Gastroenterology
2003; 124: 1866-1878.
43. Wang PL, Ohura K, Fujii T, Oido-Mori M, Kowashi Y, Kikuchi M,
et al. DNA microarray analysis of human gingival fibroblasts from
healthy and inflammatory gingival tissues. Biochem Biophys Res
Commun 2003; 305: 970-973.
44. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The
lipopolysaccharide-activated toll-like receptor (TLR)-4 induces
synthesis of the closely related receptor TLR-2 in adipocytes. J
Biol Chem 2000; 275: 24255-24263.
45. Backhed F, Hornef M. Toll-like receptor 4-mediated signaling
by epithelial surfaces: necessity or threat? Microbes Infect 2003;
5: 951-959.
46. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial
cells fight against respiratory pathogens. Eur Respir J 2004; 23:
327-333.
47. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation
of airway epithelial cells by toll-like receptor agonists. Am J Respir
Cell Mol Biol 2004; 31: 358-364.
48. Soong G, Reddy B, Sokol S, Adamo R, Prince A. TLR2 is mobilized
into an apical lipid raft receptor complex to signal infection in
airway epithelial cells. J Clin Invest 2004; 113: 1482-1489.
49. Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, et al. Activation of
NF-kappa B by nontypeable Hemophilus influenzae is mediated
by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I
kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways
in epithelial cells. Proc Natl Acad Sci USA 2001; 98: 8774-8779.
50. Wang X, Zhang Z, Louboutin JP, Moser C, Weiner DJ, Wilson JM.
Airway epithelia regulate expression of human beta-defensin 2
through Toll-like receptor 2. FASEB J 2003; 17: 1727-1729.